CRISPR used to restore retinal function – Drug Target Review
Drug Target Review |
CRISPR used to restore retinal function
Drug Target Review Researchers from Columbia University have developed a new technique for the powerful gene editing tool CRISPR to restore retinal function in mice afflicted by a degenerative retinal disease, retinitis pigmentosa. This is the first time researchers have … New technique may help patients overcome various eye diseases A new 'vision' |
